A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
|2||Active, not recruiting||
Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
CD133+ Cell Therapy for Refractory Coronary Heart Disease
Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Pain
Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture
Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair
† Study has passed its completion date and status has not been verified in more than two years.